Episurf Medical

In order to facilitate settlement of an acquisition of 9,526,170 Class B shares in Episurf Medical AB (publ) ("Episurf" or the "Company") by Sacajo Investments LLC ("Sacajo"), a trust with the Company's Senior Advisor Niles Noblitt as first member, Sacajo and Pål Ryfors, CEO of Episurf, have agreed that Pål Ryfors shall hold the shares during an interim period. Consequently, Pål Ryfors will acquire 9,526,170 Class B shares in Episurf from Sacajo for a purchase price of SEK 2,286,280.80, corresponding to SEK 0.24 per share. Payment for the shares is made by Pål Ryfors issuing a promissory note to Sacajo. The promissory note is interest free and Sacajo will bear all taxes and other costs related to the share transfer. The transferred shares are subject to a put and call option, pursuant to which Sacajo may request to acquire all 9,526,170 Class B shares from Pål Ryfors and Pål Ryfors may request to sell all 9,526,170 Class B shares to Sacajo, in both cases for a purchase of SEK 0.24 per share.